1. Бойко А.Н., Кабанов А.А., Еськина Т.А. и др. Эффективность фезама у больных с хронической ишемией мозга. Журн. неврол. и психиатр. им. С.С.Корсакова. 2005; 105 (1): 36–41.
2. Гусев Е.И., Никифоров А.С., Бурд Г.С. Основные неврологические синдромы и симптомы. М.: Медицина, 2001.
3. Гусев Е.И., Скворцова В.И. Ишемия головного мозга. М.: Медицина, 2001.
4. Гусев Е.И., Белоусов Ю.Б., Бойко А.Н. и др. Общие принципы проведения фармакоэкономических исследований в неврологии. Методические рекомендации. М.: Издатель Е.Разумова, 2003.
5. Abruzzo T, Tong F, Waldrop A et al. Basilar artery stent angioplasty for symptomatic intracranial athero-occlusive disease: complications and late midterm clinical outcomes. AJNR Am J Neuroradiol 2007; 28 (5): 808–15.
6. Brown RD, Petty GW, O'Fallon M et. al. Incidence of transient ischemic attack in Rochester, Minnesota, 1985–1989. Stroke 1998; 29: 2109–13.
7. Bulsara K, Velez D, Villavicencio A et al. Rotational vertebral artery insufficiency resulting from cervical spondylosis: case report and review of the literature. Surg Neurol 2006; 65 (6): 625–7.
8. Cesarani A, Alpini D, Monti B et al.The treatment of acute vertigo. Neurol Sci 2004; Suppl. 1: S26–30.
9. Cirek Z, Schwarz M, Baumann W, Novotny M. Efficacy and Tolerability of a Fixed Combination of Cinnarizine and Dimenhydrinate versus Betahistine in the Treatment of Otogenic Vertigo: A Double-Blind, Randomised Clinical Study. Clin Drug Investig. 2005; 25 (6): 377–89.
10. Coward L, McCabe D, Ederle J et al. Long-term outcome after angioplasty and stenting for symptomatic vertebral artery stenosis compared with medical treatment in the Carotid And Vertebral Artery Transluminal Angioplasty Study (CAVATAS): a randomized trial. Stroke 2007; 38 (5): 1526–30.
11. Cullen J, Hall S, Allen R. Effect of betahistine dihydrochloride compared with cinnarizine on induced vestibular nystagmus. Clin Otolaryngol Allied Sci 1989; 14 (6): 485–7.
12. Enderby P, Broeckx J, Hospers W et al. Effect of piracetam on recovery and rehabilitation after stroke: a double-blind, placebo-controlled study. Clin Neuropharmacol 1994; 17 (4): 320–31.
13. Fiorella D, Chow M, Anderson M et al. A 7-year experience with balloon-mounted coronary stents for the treatment of symptomatic vertebrobasilar intracranial atheromatous disease. Neurosurgery 2007; 61 (2): 236–42.
14. Georgiadis A, Yamamoto Y, Kwan S et al. Anatomy of Sensory Findings in Patients With Posterior Cerebral Artery Territory Infarction. Arch Neurol 1999; 56: 835–8.
15. Gupta R, Al-Ali F, Thomas A et al. Safety, feasibility, and short-term follow-up of drug-eluting stent placement in the intracranial and extracranial circulation. Stroke 2006; 37 (10): 2562–6.
16. Kawasaki A, Purvin V. Isolated IVth (trochlear) nerve palsy due to basilar artery dolichoectasia. Klin Monatsbl Augenheilkd 2006; 223 (5): 459–61.
17. Lee H, Cho Y. Auditory disturbance as a prodrome of anterior inferior cerebellar artery infarction. J Neurol Neurosurg Psychiat 2003; 74: 1644–8.
18. Maranhão-Filho P, Souto A, Nogueira J. Isolated Pathetick nerve paresis by compression from a dolichoectatic basilar artery: case report. Arq Neuropsiquiatr 2007; 65 (1): 176–8.
19. Marti-Masso J, Poza J. Cinnarizine-induced parkinsonism: ten years later. Mov Disord 1998; 13 (3): 453–6.
20. Martin P. Vertebrobasilar ischemia. Q J Med 1998; 91: 799–811.
21. Mitchell J. The vertebral artery: a review of anatomical, histopathological and functional factors influencing blood flow to the hindbrain. Physiother Theory Pract 2005; 21 (1): 23–36.
22. Ogino M, Kawamoto T, Asakuno K et al. Proper management of the rotational vertebral artery occlusion secondary to spondylosis. Clin Neurol Neurosurg 2001; 103 (4): 250–3.
23. Oosterveld W. The effectiveness of piracetam in vertigo. Pharmacopsychiatry 1999; 32 (Suppl. 1): 54–60.
24. Phatouros CC, Lefler JE, Higashida RT et al. Am J Neuroradiol 2000; 21: 1744–9.
25. Pianese C, Hidalgo L, Gonz_lez R et al. New approaches to the management of peripheral vertigo: efficacy and safety of two calcium antagonists in a 12-week, multinational, double-blind study. Otol Neurotol 2002; 23 (3): 357–63.
26. Pons Rocher F. The effect of pharmacological treatment in the compensation of vertigo. An Otorrinolaringol Ibero Am 1999; 26 (3): 271–91.
27. Pytel J, Nagy G, Tóth A et al. Efficacy and tolerability of a fixed low-dose combination of cinnarizine and dimenhydrinate in the treatment of vertigo: a 4-week, randomized, double-blind, active- and placebo-controlled, parallel-group, outpatient study. Clin Ther 2007; 29 (1): 84–98.
28. Qureshi A, Ziai W, Yahia A et al. Stroke-free survival and its determinants in patients with symptomatic vertebrobasilar stenosis: a multicenter study. Neurosurgery 2003; 52 (5): 1033–9.
29. Schindler RJ. Dementia with cerebrovascular disease: the benefits of early treatment. Eur J Neurology 2005; 12 (s3): 17–21.
30. Scholtz A, Schwarz M, Baumann W et al. Treatment of vertigo due to acute unilateral vestibular loss with a fixed combination of cinnarizine and dimenhydrinate: a double-blind, randomized, parallel-group clinical study. Clin Ther 2004; 26 (6): 866–77.
31. Tariska P, Paksy A. Cognitive enhancement effect of piracetam in patients with mild cognitive impairment and dementia. Orv Hetil 2000; 141 (22): 1189–93.
32. Teive H, Troiano A, Germiniani F. Flunarizine and cinnarizine-induced parkinsonism: a historical and clinical analysis. Parkinsonism Relat Disord 2004; 10 (4): 243–5.
33. Titlic M, Tonkic A, Jukic I et al. Tinnitus caused by vertebrobasilar dolichoectasia. Bratisl Lek Listy 2007; 108 (10–11): 455–547.
34. Wityk R, Chang H-M, Rosengart A et al. Proximal extracranial vertebral artery disease in the New England Medical Center Posterior Circulation Registry. Arch Neurol 1998; 55: 470–8.